MX2022009446A - Composiciones para activacion de nrf2 mejorada y sus metodos de uso. - Google Patents

Composiciones para activacion de nrf2 mejorada y sus metodos de uso.

Info

Publication number
MX2022009446A
MX2022009446A MX2022009446A MX2022009446A MX2022009446A MX 2022009446 A MX2022009446 A MX 2022009446A MX 2022009446 A MX2022009446 A MX 2022009446A MX 2022009446 A MX2022009446 A MX 2022009446A MX 2022009446 A MX2022009446 A MX 2022009446A
Authority
MX
Mexico
Prior art keywords
compositions
methods
improved
nrf2 activation
phytochemicals
Prior art date
Application number
MX2022009446A
Other languages
English (en)
Inventor
Brooks Michael Hybertson
Joe Milton Mccord
Original Assignee
Pathways Bioscience Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pathways Bioscience Llc filed Critical Pathways Bioscience Llc
Publication of MX2022009446A publication Critical patent/MX2022009446A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

En la presente se revelan composiciones y métodos para prevenir o tratar determinadas condiciones de salud asociadas con inflamación o estrés oxidativo. Estas composiciones se preparan a partir de ingredientes que contienen productos fitoquímicos que activan las vías de Nrf2. También se revelan los efectos sinérgicos de los diferentes productos fitoquímicos.
MX2022009446A 2015-09-03 2018-03-02 Composiciones para activacion de nrf2 mejorada y sus metodos de uso. MX2022009446A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562214175P 2015-09-03 2015-09-03
US201662355810P 2016-06-28 2016-06-28

Publications (1)

Publication Number Publication Date
MX2022009446A true MX2022009446A (es) 2022-09-05

Family

ID=58188643

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018002743A MX2018002743A (es) 2015-09-03 2016-09-02 Composiciones para activacion de nrf2 mejorada y sus metodos de uso.
MX2022009446A MX2022009446A (es) 2015-09-03 2018-03-02 Composiciones para activacion de nrf2 mejorada y sus metodos de uso.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2018002743A MX2018002743A (es) 2015-09-03 2016-09-02 Composiciones para activacion de nrf2 mejorada y sus metodos de uso.

Country Status (9)

Country Link
US (1) US11413269B2 (es)
JP (1) JP6901787B2 (es)
CN (1) CN108136209A (es)
CL (1) CL2018000573A1 (es)
CO (1) CO2018003454A2 (es)
HK (1) HK1256480A1 (es)
MX (2) MX2018002743A (es)
PE (1) PE20190380A1 (es)
WO (1) WO2017041054A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3481409A4 (en) * 2016-07-11 2020-03-18 The State of Isreal, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) TREATMENT OF FOLLICULAR TONSILLITIS WITH PLANT EXTRACTS WITH CARNOSIC ACID
WO2018197394A1 (en) * 2017-04-27 2018-11-01 Dsm Ip Assets B.V. Use of withania somnifera extract to protect against air pollution related diseases

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888514A (en) * 1997-05-23 1999-03-30 Weisman; Bernard Natural composition for treating bone or joint inflammation
US9265808B2 (en) * 2004-03-23 2016-02-23 Lifeline Nutraceuticals Corporation Compositions for alleviating inflammation and oxidative stress in a mammal
WO2006073042A1 (ja) * 2005-01-05 2006-07-13 Toagosei Co., Ltd. Ｎｒｆ２依存遺伝子の活性化剤
CA2648273A1 (en) * 2006-04-03 2007-10-11 Nestec S.A. Nutritional compositions for promotion of bone growth and maintenance of bone health and methods regarding same
CA2755014A1 (en) 2008-03-10 2009-09-17 University Of Louisville Research Foundation, Inc. Methods and compositions for controlled delivery of phytochemical agents
CN102164508B (zh) 2008-07-31 2015-04-01 嘉康利公司 具有增加的抗氧化活性的麝香葡萄组合物
JP2011057654A (ja) * 2009-09-14 2011-03-24 Iwate Univ メタボリックシンドローム治療又は予防薬、及び脂肪細胞分化抑制方法
WO2011075843A1 (en) 2009-12-24 2011-06-30 The Royal Institution For The Avancement Of Learning/Mcgill University Compositions and methods for preventing and treating diseases and environmentally induced health disorders
KR101254847B1 (ko) * 2010-05-27 2013-04-15 한림대학교 산학협력단 실리비닌(silibinin)을 포함하는 골다공증 치료 및 예방용 조성물
WO2012142511A2 (en) 2011-04-15 2012-10-18 Md Matrix Health Llc Dba Md Matrix Health Inc Orthomolecular compositions and their use in stabilizing the extracellular matrix
MX347457B (es) * 2012-01-16 2017-04-27 Héctor De Jesús Velez-Rivera Fitocomposición para el tratamiento de dolores relacionados con enfermedades articulares.
JP2013209351A (ja) * 2012-03-30 2013-10-10 Sunstar Inc 抗酸化機能亢進剤
US20140287071A1 (en) * 2013-01-17 2014-09-25 Lifevantage Corporation Veterinary supplements
WO2014151891A1 (en) * 2013-03-14 2014-09-25 Walley Darlene Topical products
WO2015008301A1 (en) * 2013-07-17 2015-01-22 Council Of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue
WO2016037971A1 (en) * 2014-09-08 2016-03-17 Bios Line S.P.A. Compositions comprising glucosinolates precursors of sulforaphane in combination with extracts of rosemary

Also Published As

Publication number Publication date
JP6901787B2 (ja) 2021-07-14
CO2018003454A2 (es) 2018-08-31
PE20190380A1 (es) 2019-03-08
MX2018002743A (es) 2018-06-06
US11413269B2 (en) 2022-08-16
US20180250264A1 (en) 2018-09-06
CN108136209A (zh) 2018-06-08
HK1256480A1 (zh) 2019-09-27
WO2017041054A1 (en) 2017-03-09
CL2018000573A1 (es) 2019-01-11
JP2018529763A (ja) 2018-10-11

Similar Documents

Publication Publication Date Title
IL268406A (en) Preparations and methods for treating hemoglobin diseases
MX2018011114A (es) Métodos y composiciones relacionadas con crispr/cas para el tratamiento de beta hemoglobinopatías.
NZ730865A (en) Peptides having anti-inflammatory properties
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
EP3334484A4 (en) COMPOSITIONS AND METHODS THAT PROMOTE HYPOXIA OR HYPOXIC RESPONSE FOR THE TREATMENT AND PREVENTION OF MITOCHONDRIAL DYSFUNCTION AND OXIDATIVE STRESS DISORDERS
GB2578539B (en) Compositions and methods for preventing or treating muscle conditions
EP3576776A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OF HEART DEFECTS
AU2018297285A1 (en) Compositions and methods for treating or preventing endocrine FGF-linked diseases
MX2022007436A (es) Inhibidores de la autotaxina y sus usos.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2018009325A (es) Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn).
IL266441B (en) Synergistic herbal compositions with prebiotic properties for the treatment of acne
EP3609525A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OR PREVENTION OF INTESTINAL PERMEABILITY DISORDERS
PL3280423T3 (pl) Kompozycje i sposoby do synergistycznego leczenia glikokaliksu
IL263477A (en) Compositions and methods for the treatment or prevention of oxalate-related disorders
SG11202012055PA (en) Methods and compositions for preventing or treating calciphylaxis
PH12020551071A1 (en) Compositions and methods for treating retinal disorders
MX2017014456A (es) Usos terapeuticos de l-4-cloroquinurenina.
HK1257853A1 (zh) 用於治療和預防放射性皮炎的組合物和方法
GB2543723A (en) Polyphenol compositions
HK1258999A1 (zh) 用於治療肝臟和維持肝臟健康的組合物、方法和藥物組合物
MX2022009446A (es) Composiciones para activacion de nrf2 mejorada y sus metodos de uso.
GB202001422D0 (en) Compositions and methods for preventing or treating nephrolithiasis
WO2016109002A3 (en) Methods and compositions for the treatment of radiation-related disorders
IL272147A (en) Methods and preparations for the treatment of cancer